KATHLEEN NICOL: Open Payments
NPI 1801131727 · BEAVER FALLS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$842 in 44 payments from 12 companies in 2025. Trend: 2023 $15 · 2024 $283 · 2025 $842
Food & beverage: $842
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $207 |
| Amgen Inc. | 8 | $153 |
| GlaxoSmithKline, LLC. | 5 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $87 |
| Lilly USA, LLC | 4 | $86 |
| ABBVIE INC. | 3 | $53 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| ACADIA Pharmaceuticals Inc | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: EVENITY, TRELEGY ELLIPTA, Wegovy, JARDIANCE, MOUNJARO, Ozempic, Rybelsus, QULIPTA.
Industry payments across PA — which companies pay providers there.
